Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges

Publikation: Bidrag til tidsskriftReviewForskning

Standard

Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development : importance of sex- and age-specific reference ranges. / Hagen, Casper P; Aksglaede, Lise; Sørensen, Kaspar; Mouritsen, Annette; Juul, Anders.

I: Pediatric Endocrinology Reviews, Bind 9 Suppl 1, 2011, s. 525-8.

Publikation: Bidrag til tidsskriftReviewForskning

Harvard

Hagen, CP, Aksglaede, L, Sørensen, K, Mouritsen, A & Juul, A 2011, 'Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges', Pediatric Endocrinology Reviews, bind 9 Suppl 1, s. 525-8.

APA

Hagen, C. P., Aksglaede, L., Sørensen, K., Mouritsen, A., & Juul, A. (2011). Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges. Pediatric Endocrinology Reviews, 9 Suppl 1, 525-8.

Vancouver

Hagen CP, Aksglaede L, Sørensen K, Mouritsen A, Juul A. Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges. Pediatric Endocrinology Reviews. 2011;9 Suppl 1:525-8.

Author

Hagen, Casper P ; Aksglaede, Lise ; Sørensen, Kaspar ; Mouritsen, Annette ; Juul, Anders. / Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development : importance of sex- and age-specific reference ranges. I: Pediatric Endocrinology Reviews. 2011 ; Bind 9 Suppl 1. s. 525-8.

Bibtex

@article{f0c06a383088462e88d4fca3a051de39,
title = "Clinical use of anti-M{\"u}llerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges",
abstract = "Determination of postnatal AMH levels in circulation has been used for decades when evaluating a child with ambiguous genitalia. We describe the age- and gender-specific changes of postnatal AMH serum levels to enable an appropriate clinical use of AMH assessment in pediatric endocrinology. In males, cord blood AMH is measurable at high levels (mean 148 (53-340) pmol/L), whereas AMH is undetectable (54%) or very low (95% CI: <2-16 pmol/L) in female infants. AMH is constant through childhood in both sexes, boys having approximately 35 times higher levels than girls with no overlapping between the sexes until puberty. Ambiguous genitalia due to impaired androgen secretion or action may be a result of various conditions with low, normal or high AMH. Furthermore, low AMH is a marker of premature ovarian failure in Turner Syndrome girls. Measurement of AMH is an important tool in assessing gonadal function in children. In this context, detailed normative data are essential.",
author = "Hagen, {Casper P} and Lise Aksglaede and Kaspar S{\o}rensen and Annette Mouritsen and Anders Juul",
year = "2011",
language = "English",
volume = "9 Suppl 1",
pages = "525--8",
journal = "Pediatric Endocrinology Reviews",
issn = "1565-4753",
publisher = "YS Medical Media Ltd.",

}

RIS

TY - JOUR

T1 - Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development

T2 - importance of sex- and age-specific reference ranges

AU - Hagen, Casper P

AU - Aksglaede, Lise

AU - Sørensen, Kaspar

AU - Mouritsen, Annette

AU - Juul, Anders

PY - 2011

Y1 - 2011

N2 - Determination of postnatal AMH levels in circulation has been used for decades when evaluating a child with ambiguous genitalia. We describe the age- and gender-specific changes of postnatal AMH serum levels to enable an appropriate clinical use of AMH assessment in pediatric endocrinology. In males, cord blood AMH is measurable at high levels (mean 148 (53-340) pmol/L), whereas AMH is undetectable (54%) or very low (95% CI: <2-16 pmol/L) in female infants. AMH is constant through childhood in both sexes, boys having approximately 35 times higher levels than girls with no overlapping between the sexes until puberty. Ambiguous genitalia due to impaired androgen secretion or action may be a result of various conditions with low, normal or high AMH. Furthermore, low AMH is a marker of premature ovarian failure in Turner Syndrome girls. Measurement of AMH is an important tool in assessing gonadal function in children. In this context, detailed normative data are essential.

AB - Determination of postnatal AMH levels in circulation has been used for decades when evaluating a child with ambiguous genitalia. We describe the age- and gender-specific changes of postnatal AMH serum levels to enable an appropriate clinical use of AMH assessment in pediatric endocrinology. In males, cord blood AMH is measurable at high levels (mean 148 (53-340) pmol/L), whereas AMH is undetectable (54%) or very low (95% CI: <2-16 pmol/L) in female infants. AMH is constant through childhood in both sexes, boys having approximately 35 times higher levels than girls with no overlapping between the sexes until puberty. Ambiguous genitalia due to impaired androgen secretion or action may be a result of various conditions with low, normal or high AMH. Furthermore, low AMH is a marker of premature ovarian failure in Turner Syndrome girls. Measurement of AMH is an important tool in assessing gonadal function in children. In this context, detailed normative data are essential.

M3 - Review

VL - 9 Suppl 1

SP - 525

EP - 528

JO - Pediatric Endocrinology Reviews

JF - Pediatric Endocrinology Reviews

SN - 1565-4753

ER -

ID: 48483965